Pavel Svirin

Rivaroxaban compared with standard anticoagulants for the treatment of acute venous thromboembolism in children: a randomised, controlled, phase 3 trial

Christoph Male, Anthonie W.A. Lensing, Joseph S. Palumbo et al. · The Lancet Haematology · 2019 · 315 citations · Full text

Medicine, Pediatrics, Pharmacotherapy +13

Dabigatran etexilate for the treatment of acute venous thromboembolism in children (DIVERSITY): a randomised, controlled, open-label, phase 2b/3, non-inferiority trial

Leonardo R. Brandão, Matteo Luciani, Lisa Bomgaars et al. · The Lancet Haematology · 2020 · 149 citations · Full text

Medicine, Pediatrics, Pharmacotherapy +12

Safety of dabigatran etexilate for the secondary prevention of venous thromboembolism in children

Leonardo R. Brandão, Manuela Albisetti, Lisa Bomgaars et al. · Blood · 2019 · 93 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +16

First prospective report on immune tolerance in poor risk haemophilia A inhibitor patients with a single factor VIII/von Willebrand factor concentrate in an observational immune tolerance induction study

W. Kreuz, Carmen Escuriola Ettingshausen, Vladimír Vdovin et al. · Haemophilia · 2015 · 57 citations · Full text

Life Sciences, Hematology, Immunology +11

Use of recombinant factor VIIa in the management of severe bleeding episodes in patients with Bernard–Soulier syndrome

Margareth C. Ozelo, Pavel Svirin · Annals of Hematology · 2005 · 49 citations

Medicine, Hematology, Hemostasis +10